Prognostic Stage 2 Breast Cancer AJCC v8 Recruiting Phase 2 Trials for Trastuzumab emtansine (DB05773)

Also known as: Prognostic Stage II Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0140767 (Prognostic Stage 2 Breast Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04266249CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted TherapyTreatment